| Rex A Outtrim, MD | |
|
3723 W 12600 S, Riverton, UT 84065-7295 | |
| (801) 285-4590 | |
| Not Available |
| Full Name | Rex A Outtrim |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 32 Years |
| Location | 3723 W 12600 S, Riverton, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558355313 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 5006181205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Intermountain Medical Center | Murray, UT | Hospital |
| Riverton Hospital | Riverton, UT | Hospital |
| Alta View Hospital | Sandy, UT | Hospital |
| Lds Hospital | Salt lake city, UT | Hospital |
| Park City Hospital | Park city, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
Ichor Medical Systems (Ichor) and Profectus Biosciences (Profectus) announced today that they have entered into a long-term development, license, and supply Agreement providing Profectus with commercial access to Ichor's TriGrid™ Delivery System (TriGrid™) for the clinical development of its DNA vaccine programs, with an option for Ichor to co-develop.
A drug commonly used to treat gout may help maintain kidney disease patients' health, according to an analysis appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). The research is the first to show that allopurinol treatment in patients with chronic kidney disease (CKD) decreases inflammation, slows the progression of kidney disease, and reduces patients' risk of experiencing a cardiovascular event or being hospitalized.
Cegedim Relationship Management, the world's leading provider of Life Sciences-specific Customer Relationship Management solutions, today issued the results of the 2010 European Trends in Aggregate Spend, Transparency, and Disclosure Report, a market research study conducted through September and October of this year.
W.L. Gore & Associates (Gore) today announced that it has received European CE Mark approval for the next generation GORE TAG® Thoracic Endoprosthesis. The device is available in an expanded portfolio of sizes to meet a broad range of patient needs and was engineered to treat multiple etiologies including thoracic aortic aneurysms (TAAs), traumatic aortic transections and thoracic aortic dissections.
› Verified 5 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
Ichor Medical Systems (Ichor) and Profectus Biosciences (Profectus) announced today that they have entered into a long-term development, license, and supply Agreement providing Profectus with commercial access to Ichor's TriGrid™ Delivery System (TriGrid™) for the clinical development of its DNA vaccine programs, with an option for Ichor to co-develop.
A drug commonly used to treat gout may help maintain kidney disease patients' health, according to an analysis appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). The research is the first to show that allopurinol treatment in patients with chronic kidney disease (CKD) decreases inflammation, slows the progression of kidney disease, and reduces patients' risk of experiencing a cardiovascular event or being hospitalized.
Cegedim Relationship Management, the world's leading provider of Life Sciences-specific Customer Relationship Management solutions, today issued the results of the 2010 European Trends in Aggregate Spend, Transparency, and Disclosure Report, a market research study conducted through September and October of this year.
W.L. Gore & Associates (Gore) today announced that it has received European CE Mark approval for the next generation GORE TAG® Thoracic Endoprosthesis. The device is available in an expanded portfolio of sizes to meet a broad range of patient needs and was engineered to treat multiple etiologies including thoracic aortic aneurysms (TAAs), traumatic aortic transections and thoracic aortic dissections.
› Verified 5 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Ichor Medical Systems (Ichor) and Profectus Biosciences (Profectus) announced today that they have entered into a long-term development, license, and supply Agreement providing Profectus with commercial access to Ichor's TriGrid™ Delivery System (TriGrid™) for the clinical development of its DNA vaccine programs, with an option for Ichor to co-develop.
A drug commonly used to treat gout may help maintain kidney disease patients' health, according to an analysis appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). The research is the first to show that allopurinol treatment in patients with chronic kidney disease (CKD) decreases inflammation, slows the progression of kidney disease, and reduces patients' risk of experiencing a cardiovascular event or being hospitalized.
Cegedim Relationship Management, the world's leading provider of Life Sciences-specific Customer Relationship Management solutions, today issued the results of the 2010 European Trends in Aggregate Spend, Transparency, and Disclosure Report, a market research study conducted through September and October of this year.
W.L. Gore & Associates (Gore) today announced that it has received European CE Mark approval for the next generation GORE TAG® Thoracic Endoprosthesis. The device is available in an expanded portfolio of sizes to meet a broad range of patient needs and was engineered to treat multiple etiologies including thoracic aortic aneurysms (TAAs), traumatic aortic transections and thoracic aortic dissections.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rex A Outtrim, MD 5121 S Cottonwood St, Suite 520, Salt Lake City, UT 84107-5701 Ph: (801) 507-3500 | Rex A Outtrim, MD 3723 W 12600 S, Riverton, UT 84065-7295 Ph: (801) 285-4590 |
News Archive
Ichor Medical Systems (Ichor) and Profectus Biosciences (Profectus) announced today that they have entered into a long-term development, license, and supply Agreement providing Profectus with commercial access to Ichor's TriGrid™ Delivery System (TriGrid™) for the clinical development of its DNA vaccine programs, with an option for Ichor to co-develop.
A drug commonly used to treat gout may help maintain kidney disease patients' health, according to an analysis appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). The research is the first to show that allopurinol treatment in patients with chronic kidney disease (CKD) decreases inflammation, slows the progression of kidney disease, and reduces patients' risk of experiencing a cardiovascular event or being hospitalized.
Cegedim Relationship Management, the world's leading provider of Life Sciences-specific Customer Relationship Management solutions, today issued the results of the 2010 European Trends in Aggregate Spend, Transparency, and Disclosure Report, a market research study conducted through September and October of this year.
W.L. Gore & Associates (Gore) today announced that it has received European CE Mark approval for the next generation GORE TAG® Thoracic Endoprosthesis. The device is available in an expanded portfolio of sizes to meet a broad range of patient needs and was engineered to treat multiple etiologies including thoracic aortic aneurysms (TAAs), traumatic aortic transections and thoracic aortic dissections.
› Verified 5 days ago
Richard Mccurry Patten, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3741 W. 12600 S., Riverton Hospital, Riverton, UT 84065 Phone: 801-285-2200 Fax: 801-285-2211 | |
Dr. Garrett Bird, MD, CM Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4063 W 12600 S # Sabs, Riverton, UT 84096 Phone: 801-935-8180 Fax: 801-931-2307 | |
Dr. Marcellus Saka Assiago, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12523 S Creek Meadow Rd Ste 111, Riverton, UT 84065 Phone: 801-288-2634 Fax: 801-288-1186 | |
Dr. Ying Ning, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 3723 W 12600 S Bldg 2, Ste 350, Riverton, UT 84065 Phone: 801-285-4750 | |
Brett W Doxey, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3741 W 12600 S, #470, Riverton, UT 84065 Phone: 801-727-4280 Fax: 801-254-8331 | |
Dr. Eric Allen, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3723 W 12600 S Ste 270, Riverton, UT 84065 Phone: 801-285-4600 |